{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:36Z","timestamp":1793413476439,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07076"],"award-info":[{"award-number":["20K07076"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08321"],"award-info":[{"award-number":["17K08321"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11064-022-03622-z","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T12:02:44Z","timestamp":1653134564000},"page":"2333-2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preventive Effect of Betaine Against Cognitive Impairments in Amyloid \u03b2 Peptide-Injected Mice Through Sirtuin1 in Hippocampus"],"prefix":"10.1007","volume":"47","author":[{"given":"Daisuke","family":"Ibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Ohmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Nakasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Takaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-310X","authenticated-orcid":false,"given":"Masayuki","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"3622_CR1","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K (2021) Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement (NY) 7:e12179","journal-title":"Alzheimers Dement (NY)"},{"key":"3622_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0165-6147(02)02056-4","volume":"23","author":"AM Palmer","year":"2002","unstructured":"Palmer AM (2002) Pharmacotherapy for Alzheimer\u2019s disease: progress and prospects. Trends Pharmacol Sci 23:426\u2013433","journal-title":"Trends Pharmacol Sci"},{"key":"3622_CR3","doi-asserted-by":"publisher","first-page":"b158","DOI":"10.1136\/bmj.b158","volume":"338","author":"A Burns","year":"2009","unstructured":"Burns A, Iliffe S (2009) Alzheimer\u2019s disease. BMJ 338:b158","journal-title":"BMJ"},{"key":"3622_CR4","doi-asserted-by":"publisher","first-page":"e015746","DOI":"10.1136\/bmjopen-2016-015746","volume":"7","author":"F Bature","year":"2017","unstructured":"Bature F, Guinn BA, Pang D, Pappas Y (2017) Signs and symptoms preceding the diagnosis of Alzheimer\u2019s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open 7:e015746","journal-title":"BMJ Open"},{"key":"3622_CR5","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2032s disease: causes and treatment. Molecules 25:5789","journal-title":"Molecules"},{"key":"3622_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1042\/BST0351219","volume":"35","author":"MJ Rowan","year":"2007","unstructured":"Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R (2007) Synaptic memory mechanisms: Alzheimer\u2019s disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 35:1219\u20131223","journal-title":"Biochem Soc Trans"},{"key":"3622_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exger.2016.12.006","volume":"94","author":"M Barron","year":"2017","unstructured":"Barron M, Gartlon J, Dawson LA, Atkinson PJ, Pardon MC (2017) A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer\u2019s disease. Exp Gerontol 94:103\u2013107","journal-title":"Exp Gerontol"},{"key":"3622_CR8","first-page":"316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid Med Cell Longev 2013:316523","journal-title":"Oxid Med Cell Longev"},{"key":"3622_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1745-7254.2006.00347.x","volume":"27","author":"F Fang","year":"2006","unstructured":"Fang F, Liu GT (2006) Protective effects of compound FLZ on beta-amyloid peptide-(25\u201335)-induced mouse hippocampal injury and learning and memory impairment. Acta Pharmacol Sin 27:651\u2013658","journal-title":"Acta Pharmacol Sin"},{"key":"3622_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204\u20131222","journal-title":"Cell"},{"key":"3622_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1124\/jpet.108.141309","volume":"327","author":"T Alkam","year":"2008","unstructured":"Alkam T, Nitta A, Mizoguchi H, Itoh A, Murai R, Nagai T, Yamada K, Nabeshima T (2008) The extensive nitration of neurofilament light chain in the hippocampus is associated with the cognitive impairment induced by amyloid beta in mice. J Pharmacol Exp Ther 327:137\u2013147","journal-title":"J Pharmacol Exp Ther"},{"key":"3622_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2007.12.014","volume":"189","author":"T Alkam","year":"2008","unstructured":"Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T (2008) Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice. Behav Brain Res 189:100\u2013106","journal-title":"Behav Brain Res"},{"key":"3622_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","volume":"706","author":"T Maurice","year":"1996","unstructured":"Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706:181\u2013193","journal-title":"Brain Res"},{"key":"3622_CR14","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.00-0719fje","volume":"15","author":"MH Tran","year":"2001","unstructured":"Tran MH, Yamada K, Olariu A, Mizuno M, Ren XH, Nabeshima T (2001) Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. Faseb J 15:1407\u20131409","journal-title":"Faseb J"},{"key":"3622_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/A:1021761310435","volume":"33","author":"VV Trubetskaya","year":"2003","unstructured":"Trubetskaya VV, Stepanichev MY, Onufriev MV, Lazareva NA, Markevich VA, Gulyaeva NV (2003) Administration of aggregated beta-amyloid peptide (25\u201335) induces changes in long-term potentiation in the hippocampus in vivo. Neurosci Behav Physiol 33:95\u201398","journal-title":"Neurosci Behav Physiol"},{"key":"3622_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2018.10.037","volume":"842","author":"D Ibi","year":"2019","unstructured":"Ibi D, Tsuchihashi A, Nomura T, Hiramatsu M (2019) Involvement of GAT2\/BGT-1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid beta peptide-injected mice. Eur J Pharmacol 842:57\u201363","journal-title":"Eur J Pharmacol"},{"key":"3622_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1474-9726.2010.00548.x","volume":"9","author":"G Donmez","year":"2010","unstructured":"Donmez G, Guarente L (2010) Aging and disease: connections to sirtuins. Aging Cell 9:285\u2013290","journal-title":"Aging Cell"},{"key":"3622_CR18","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1007\/s12035-017-0646-8","volume":"55","author":"PL Wencel","year":"2018","unstructured":"Wencel PL, Lukiw WJ, Strosznajder JB, Strosznajder RP (2018) Inhibition of poly(ADP-ribose) polymerase-1 enhances gene expression of selected sirtuins and APP cleaving enzymes in amyloid beta cytotoxicity. Mol Neurobiol 55:4612\u20134623","journal-title":"Mol Neurobiol"},{"key":"3622_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.npep.2018.07.001","volume":"71","author":"L Rizzi","year":"2018","unstructured":"Rizzi L, Roriz-Cruz M (2018) Sirtuin 1 and Alzheimer\u2019s disease: an up-to-date review. Neuropeptides 71:54\u201360","journal-title":"Neuropeptides"},{"key":"3622_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/ajcn\/80.3.539","volume":"80","author":"SA Craig","year":"2004","unstructured":"Craig SA (2004) Betaine in human nutrition. Am J Clin Nutr 80:539\u2013549","journal-title":"Am J Clin Nutr"},{"key":"3622_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/jn\/133.5.1302","volume":"133","author":"SH Zeisel","year":"2003","unstructured":"Zeisel SH, Mar MH, Howe JC, Holden JM (2003) Concentrations of choline-containing compounds and betaine in common foods. J Nutr 133:1302\u20131307","journal-title":"J Nutr"},{"key":"3622_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tplants.2008.06.007","volume":"13","author":"TH Chen","year":"2008","unstructured":"Chen TH, Murata N (2008) Glycinebetaine: an effective protectant against abiotic stress in plants. Trends Plant Sci 13:499\u2013505","journal-title":"Trends Plant Sci"},{"key":"3622_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.nu.14.070194.001413","volume":"14","author":"SH Zeisel","year":"1994","unstructured":"Zeisel SH, Blusztajn JK (1994) Choline and human nutrition. Annu Rev Nutr 14:269\u2013296","journal-title":"Annu Rev Nutr"},{"key":"3622_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fphys.2014.00159","volume":"5","author":"SA Kempson","year":"2014","unstructured":"Kempson SA, Zhou Y, Danbolt NC (2014) The betaine\/GABA transporter and betaine: roles in brain, kidney, and liver. Front Physiol 5:159","journal-title":"Front Physiol"},{"key":"3622_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cca.2016.04.002","volume":"458","author":"T Kumar","year":"2016","unstructured":"Kumar T, Sharma GS, Singh LR (2016) Homocystinuria: therapeutic approach. Clin Chim Acta 458:55\u201362","journal-title":"Clin Chim Acta"},{"key":"3622_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13023-019-1036-2","volume":"14","author":"V Valayannopoulos","year":"2019","unstructured":"Valayannopoulos V, Schiff M, Guffon N, Nadjar Y, Garc\u00eda-Cazorla A, Martinez-Pardo Casanova M, Cano A, Couce ML, Dalmau J, Pe\u00f1a-Quintana L, Rigalleau V, Touati G, Aldamiz-Echevarria L, Cathebras P, Eyer D, Brunet D, Damaj L, Dobbelaere D, Gay C, Hi\u00e9ronimus S, Levrat V, Maillot F (2019) Betaine anhydrous in homocystinuria: results from the RoCH registry. Orphanet J Rare Dis 14:66","journal-title":"Orphanet J Rare Dis"},{"key":"3622_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ebiom.2019.05.062","volume":"45","author":"T Ohnishi","year":"2019","unstructured":"Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, Hino M, Mataga N, Hayashi-Takagi A, Hashimoto K, Kunii Y, Kakita A, Yabe H, Yoshikawa T (2019) Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine 45:432\u2013446","journal-title":"EBioMedicine"},{"key":"3622_CR28","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00213-016-4359-x","volume":"233","author":"JC Lin","year":"2016","unstructured":"Lin JC, Lee MY, Chan MH, Chen YC, Chen HH (2016) Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice. Psychopharmacology 233:3223\u20133235","journal-title":"Psychopharmacology"},{"key":"3622_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jad.2020.03.095","volume":"272","author":"Y Qu","year":"2020","unstructured":"Qu Y, Zhang K, Pu Y, Chang L, Wang S, Tan Y, Wang X, Zhang J, Ohnishi T, Yoshikawa T, Hashimoto K (2020) Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. J Affect Disord 272:66\u201376","journal-title":"J Affect Disord"},{"key":"3622_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-200972","volume":"79","author":"D Ibi","year":"2021","unstructured":"Ibi D, Hirashima K, Kojima Y, Sumiya K, Kondo S, Yamamoto M, Ando T, Hiramatsu M (2021) Preventive effects of continuous betaine intake on cognitive impairment and aberrant gene expression in hippocampus of 3xTg mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 79:639\u2013652","journal-title":"J Alzheimers Dis"},{"key":"3622_CR31","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1523\/JNEUROSCI.5098-09.2010","volume":"30","author":"I Allaman","year":"2010","unstructured":"Allaman I, Gavillet M, B\u00e9langer M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30:3326\u20133338","journal-title":"J Neurosci"},{"key":"3622_CR32","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1476-5381.2010.01014.x","volume":"161","author":"M Hiramatsu","year":"2010","unstructured":"Hiramatsu M, Takiguchi O, Nishiyama A, Mori H (2010) Cilostazol prevents amyloid beta peptide(25\u201335)-induced memory impairment and oxidative stress in mice. Br J Pharmacol 161:1899\u20131912","journal-title":"Br J Pharmacol"},{"key":"3622_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","volume":"12","author":"TJ Haley","year":"1957","unstructured":"Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12\u201315","journal-title":"Br J Pharmacol Chemother"},{"key":"3622_CR34","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nn.4616","volume":"20","author":"D Ibi","year":"2017","unstructured":"Ibi D, de la Fuente RM, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, Garcia-Bea A, Kurita M, Mosley GE, Jiang Y, Christoffel DJ, Callado LF, Russo SJ, Dracheva S, Lopez-Gimenez JF, Ge Y, Escalante CR, Meana JJ, Akbarian S, Huntley GW, Gonzalez-Maeso J (2017) Antipsychotic-induced Hdac2 transcription via NF-kappaB leads to synaptic and cognitive side effects. Nat Neurosci 20:1247\u20131259","journal-title":"Nat Neurosci"},{"key":"3622_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.physbeh.2018.02.024","volume":"188","author":"D Ibi","year":"2018","unstructured":"Ibi D, Suzuki F, Hiramatsu M (2018) Effect of AceK (acesulfame potassium) on brain function under dietary restriction in mice. Physiol Behav 188:291\u2013297","journal-title":"Physiol Behav"},{"key":"3622_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","volume":"15","author":"H Jahn","year":"2013","unstructured":"Jahn H (2013) Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosci 15:445\u2013454","journal-title":"Dialogues Clin Neurosci"},{"key":"3622_CR37","doi-asserted-by":"publisher","first-page":"21745","DOI":"10.1074\/jbc.M602909200","volume":"281","author":"W Qin","year":"2006","unstructured":"Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281:21745\u201321754","journal-title":"J Biol Chem"},{"key":"3622_CR38","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.immuni.2016.05.009","volume":"44","author":"Y Wang","year":"2016","unstructured":"Wang Y, Bi Y, Chen X, Li C, Li Y, Zhang Z, Wang J, Lu Y, Yu Q, Su H, Yang H, Liu G (2016) Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4(+) T cells. Immunity 44:1337\u20131349","journal-title":"Immunity"},{"key":"3622_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10571-016-0425-5","volume":"37","author":"YC Liu","year":"2017","unstructured":"Liu YC, Gao XX, Zhang ZG, Lin ZH, Zou QL (2017) PPAR gamma coactivator 1 beta (PGC-1\u03b2) reduces mammalian target of rapamycin (mTOR) expression via a SIRT1-dependent mechanism in neurons. Cell Mol Neurobiol 37:879\u2013887","journal-title":"Cell Mol Neurobiol"},{"key":"3622_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.18632\/aging.100076","volume":"1","author":"A Purushotham","year":"2009","unstructured":"Purushotham A, Schug TT, Li X (2009) SIRT1 performs a balancing act on the tight-rope toward longevity. Aging (Albany NY) 1:669\u2013673","journal-title":"Aging (Albany NY)"},{"key":"3622_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0891-5849(88)90109-8","volume":"5","author":"JM McCord","year":"1988","unstructured":"McCord JM, Fridovich I (1988) Superoxide dismutase: the first twenty years (1968\u20131988). Free Radic Biol Med 5:363\u2013369","journal-title":"Free Radic Biol Med"},{"key":"3622_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ibror.2020.06.004","volume":"9","author":"DS Moraes","year":"2020","unstructured":"Moraes DS, Moreira DC, Andrade JMO, Santos SHS (2020) Sirtuins, brain and cognition: a review of resveratrol effects. IBRO Rep 9:46\u201351","journal-title":"IBRO Rep"},{"key":"3622_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2014.10.036","volume":"440","author":"L Ma","year":"2015","unstructured":"Ma L, Li Y (2015) SIRT1: role in cardiovascular biology. Clin Chim Acta 440:8\u201315","journal-title":"Clin Chim Acta"},{"key":"3622_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tibs.2012.12.004","volume":"38","author":"JR Revollo","year":"2013","unstructured":"Revollo JR, Li X (2013) The ways and means that fine tune Sirt1 activity. Trends Biochem Sci 38:160\u2013167","journal-title":"Trends Biochem Sci"},{"key":"3622_CR45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ijo.2012.1534","volume":"41","author":"J Wang","year":"2012","unstructured":"Wang J, Kim TH, Ahn MY, Lee J, Jung JH, Choi WS, Lee BM, Yoon KS, Yoon S, Kim HS (2012) Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. Int J Oncol 41:1101\u20131109","journal-title":"Int J Oncol"},{"key":"3622_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel T, Deng CX, Mostoslavsky R (2009) Recent progress in the biology and physiology of sirtuins. Nature 460:587\u2013591","journal-title":"Nature"},{"key":"3622_CR47","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1074\/jbc.M110.163667","volume":"286","author":"S Xiong","year":"2011","unstructured":"Xiong S, Salazar G, Patrushev N, Alexander RW (2011) FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J Biol Chem 286:5289\u20135299","journal-title":"J Biol Chem"},{"key":"3622_CR48","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.neuroscience.2009.01.017","volume":"159","author":"D Della-Morte","year":"2009","unstructured":"Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993\u20131002","journal-title":"Neuroscience"},{"key":"3622_CR49","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.4103\/1673-5374.239449","volume":"13","author":"MZ Li","year":"2018","unstructured":"Li MZ, Zheng LJ, Shen J, Li XY, Zhang Q, Bai X, Wang QS, Ji JG (2018) SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes. Neural Regen Res 13:2005\u20132013","journal-title":"Neural Regen Res"},{"key":"3622_CR50","doi-asserted-by":"publisher","first-page":"e61560","DOI":"10.1371\/journal.pone.0061560","volume":"8","author":"R Kumar","year":"2013","unstructured":"Kumar R, Chaterjee P, Sharma PK, Singh AK, Gupta A, Gill K, Tripathi M, Dey AB, Dey S (2013) Sirtuin1: a promising serum protein marker for early detection of Alzheimer\u2019s disease. PLoS ONE 8:e61560","journal-title":"PLoS ONE"},{"key":"3622_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00415-008-0774-1","volume":"255","author":"S Helisalmi","year":"2008","unstructured":"Helisalmi S, Veps\u00e4l\u00e4inen S, Hiltunen M, Koivisto AM, Salminen A, Laakso M, Soininen H (2008) Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer\u2019s disease. J Neurol 255:668\u2013673","journal-title":"J Neurol"},{"key":"3622_CR52","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI20864","volume":"113","author":"R Postina","year":"2004","unstructured":"Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113:1456\u20131464","journal-title":"J Clin Invest"},{"key":"3622_CR53","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gon\u00e7alves PR, Sakai JT, Mendes PFS, Varela ELP, Monteiro MC (2018) Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 2018:8152373","journal-title":"Oxid Med Cell Longev"},{"key":"3622_CR54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, Chhabra G, Ndiaye MA, Garcia-Peterson LM, Mack NJ, Ahmad N (2018) The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal 28:643\u2013661","journal-title":"Antioxid Redox Signal"},{"key":"3622_CR55","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/nu8050250","volume":"8","author":"D Bonnefont-Rousselot","year":"2016","unstructured":"Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8:250","journal-title":"Nutrients"},{"key":"3622_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0197-0186(95)00158-1","volume":"29","author":"LA Borden","year":"1996","unstructured":"Borden LA (1996) GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem Int 29:335\u2013356","journal-title":"Neurochem Int"},{"key":"3622_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0021-9258(18)48543-2","volume":"267","author":"A Yamauchi","year":"1992","unstructured":"Yamauchi A, Uchida S, Kwon HM, Preston AS, Robey RB, Garcia-Perez A, Burg MB, Handler JS (1992) Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity. J Biol Chem 267:649\u2013652","journal-title":"J Biol Chem"},{"key":"3622_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2152\/jmi.64.197","volume":"64","author":"Y Zamami","year":"2017","unstructured":"Zamami Y, Imanishi M, Takechi K, Ishizawa K (2017) Pharmacological approach for drug repositioning against cardiorenal diseases. J Med Invest 64:197\u2013201","journal-title":"J Med Invest"},{"key":"3622_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6:91","journal-title":"Biomedicines"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03622-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T19:44:43Z","timestamp":1700595883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03622-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3622"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03622-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of the present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures were approved by the animal ethics board of Meijo University, and followed the guidelines of the Japanese Pharmacological Society (Folia Pharmacol. Japon, 1992, 99: 35A), the Interministerial Decree of May 25th, 1987 (Ministry of Education, Japan), and the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}